Eli Lilly returns to RTP with $470M plant for diabetes drugs
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) plans to build a production facility in RTP, creating 462 jobs over the next five years,
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
